A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says Charlotte ...

Contrary to some celebrities who avoid disclosing whether they used medication to help them lose weight, Jim Gaffigan ...

The following is a satirical article from The Jerusalem Post's annual parodic Purim page, The Jerusalem Roast. Enjoy!

Dr. Oz has talked about the perks of probiotics — live microorganisms sometimes known as “good bacteria” — including ...

A study finds that significant weight loss increases the risk for individuals with cardiovascular disease. New research has ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.

At the pace with which the proportion of overweight people is growing, half of Nepal’s adult population will be obese by 2050 ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...